NCT05567523View on ClinicalTrials.gov

Safety Study of Dexmedetomidine in Elderly Under General Anesthesia

PHASE4CompletedINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

June 1, 2019

Primary Completion Date

February 28, 2022

Study Completion Date

March 30, 2022

Conditions

Hip FracturesHip Disease

Interventions

DRUG

Dexmedetomidine

In dexmedetomidine groups, patients will be pumped 0.1ml/kg of dexmedetomidine (contained dexmedetomidine 0.25/0.5/0.75µg/kg in Group D0.25/D0.5/D0.75) for 15min before anesthesia induction, following continuous infusion at the rate of 0.125ml/kg/h until the end of operation.

DRUG

Normal saline

normal saline

DRUG

Midazolam

midazolam

Trial Locations (1)

212002

Zhenjiang First People's Hospital, Zhenjiang

All Listed Sponsors

lead

Zhenjiang First People's Hospital

OTHER

NCT05567523 - Safety Study of Dexmedetomidine in Elderly Under General Anesthesia | Biotech Hunter | Biotech Hunter